GSK vs JNJ: Which Is the Better Dividend Stock?
As of Nov 6, 2026, JNJ (Johnson & Johnson) screens as the stronger dividend stock, winning 5 of 8 head-to-head metrics. GSK offers the higher yield at 3.60%, JNJ has the higher dividend-safety score, and GSK looks like the better value (its fair-value estimate is 11% below its share price).
Key facts: GSK vs JNJ
Data as of · Source: SmarterDividends data
- As of Nov 6, 2026, GSK plc (GSK) has the higher forward dividend yield at 3.60%, versus 1.97% for Johnson & Johnson (JNJ).
- As of Nov 6, 2026, SmarterDividends grades GSK's dividend safety C (60/100) and JNJ's A (93/100).
- By SmarterDividends' count as of Nov 6, 2026, GSK has raised its dividend for 2 consecutive years and JNJ for 55.
- As of Nov 6, 2026, GSK pays out 63% of its earnings as dividends and JNJ pays out 80%.
- As of Nov 6, 2026, GSK's fair-value estimate is 11% below its share price and JNJ's fair-value estimate is 27% below its share price, so GSK looks like the better value of the two on SmarterDividends' blended model.
Cite this page
SmarterDividends, "GSK vs JNJ: Dividend Yield, Safety & Value Compared," updated Nov 6, 2026, https://smarterdividends.com/compare/gsk-vs-jnj
| Metric | GSK | JNJ |
|---|---|---|
| Forward yield | 3.60% | 1.97% |
| Annual dividend | $1.82 | $5.36 |
| Payout ratio | 63% | 80% |
| Years of growth | 2 yr | 55 yr |
| 5-yr dividend growth | -4.0% | 5.2% |
| 5-yr total return | 20% | 75% |
| Dividend safety score | 60 (C) | 93 (A) |
| Fair value estimate | $44.63 | $199.73 |
| Upside to fair value | -11% | -27% |
| Frequency | quarterly | quarterly |
| Market cap | $101.0B | $655.6B |
| P/E ratio | 17.6 | 41.3 |
Higher yield
GSK
3.60%
Safer dividend
JNJ
Grade A
Faster growth
JNJ
5.2%
Better value
GSK
-11% upside
GSK vs JNJ — FAQ
Is GSK or JNJ a better dividend stock?
On the data, JNJ wins more head-to-head categories (5 vs 3). GSK offers the higher yield (3.60%), while JNJ has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.
Which has a higher dividend yield, GSK or JNJ?
GSK has the higher forward dividend yield at 3.60%, versus 1.97% for JNJ.
Is GSK or JNJ safer?
JNJ has the higher dividend-safety score (93/100 vs 60/100), reflecting stronger payout coverage and dividend-growth history.
Is GSK or JNJ better value right now?
As of Nov 6, 2026, GSK looks like the better value: its fair-value estimate is 11% below its share price (fairly valued). For JNJ, its fair-value estimate is 27% below its share price.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.